USPTO teaches how to circumvent Myriad and Prometheus

The USPTO has provided updated guidance in relation to patent eligibility of inventions involving natural products and principles in view of the Myriad and Prometheus decisions. The updated guidance provides a number of new examples specifically relating to the patent eligibility of subject matter such as vaccines, diagnostic methods and genetic screening.   Vaccine/composition claims